|
US20100151556A1
(en)
*
|
2002-03-15 |
2010-06-17 |
Cellectis |
Hybrid and single chain meganucleases and use thereof
|
|
AU2003215869B2
(en)
*
|
2002-03-15 |
2008-04-24 |
Cellectis |
Hybrid and single chain meganucleases and use thereof
|
|
WO2009095742A1
(en)
*
|
2008-01-31 |
2009-08-06 |
Cellectis |
New i-crei derived single-chain meganuclease and uses thereof
|
|
EP3202899B1
(en)
|
2003-01-28 |
2020-10-21 |
Cellectis |
Custom-made meganuclease and use thereof
|
|
AU2004263865B2
(en)
*
|
2003-08-08 |
2007-05-17 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
WO2006097784A1
(en)
*
|
2005-03-15 |
2006-09-21 |
Cellectis |
I-crei meganuclease variants with modified specificity, method of preparation and uses thereof
|
|
WO2007034262A1
(en)
*
|
2005-09-19 |
2007-03-29 |
Cellectis |
Heterodimeric meganucleases and use thereof
|
|
EP1863909B2
(en)
|
2005-03-15 |
2014-09-10 |
Cellectis |
I-crei meganuclease variants with modified specificity, method of preparation and uses thereof
|
|
EP1869186B1
(en)
|
2005-04-04 |
2010-10-13 |
Bayer BioScience N.V. |
Methods and means for removal of a selected dna sequence
|
|
US20140010797A1
(en)
*
|
2005-10-18 |
2014-01-09 |
Duke University |
Fusion Molecules of Rationally-Designed DNA-Binding Proteins and Effector Domains
|
|
ES2582091T3
(es)
*
|
2005-10-18 |
2016-09-09 |
Precision Biosciences |
Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas
|
|
WO2007060495A1
(en)
|
2005-10-25 |
2007-05-31 |
Cellectis |
I-crei homing endonuclease variants having novel cleavage specificity and use thereof
|
|
WO2007049095A1
(en)
*
|
2005-10-25 |
2007-05-03 |
Cellectis |
Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof
|
|
WO2007093836A1
(en)
|
2006-02-13 |
2007-08-23 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
|
|
US10407672B2
(en)
*
|
2006-03-27 |
2019-09-10 |
Seattle Children's Hospital |
Compositions and methods comprising the use of cell surface displayed homing endonucleases
|
|
ES2465996T3
(es)
*
|
2006-05-25 |
2014-06-09 |
Sangamo Biosciences, Inc. |
Métodos y composiciones para la inactivación genética
|
|
WO2008010009A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof
|
|
US8367890B2
(en)
|
2006-09-28 |
2013-02-05 |
Bayer Cropscience N.V. |
Methods and means for removal of a selected DNA sequence
|
|
US20100146651A1
(en)
*
|
2006-11-14 |
2010-06-10 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
|
|
WO2008059317A1
(en)
*
|
2006-11-14 |
2008-05-22 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
|
|
JP2010510222A
(ja)
*
|
2006-11-17 |
2010-04-02 |
シェーリング コーポレイション |
増殖性障害に対する併用療法
|
|
WO2008093152A1
(en)
*
|
2007-02-01 |
2008-08-07 |
Cellectis |
Obligate heterodimer meganucleases and uses thereof
|
|
CN101679959A
(zh)
*
|
2007-02-19 |
2010-03-24 |
赛莱克蒂斯公司 |
具有新的底物特异性的laglidadg归巢核酸内切酶变体及其用途
|
|
WO2008102199A1
(en)
*
|
2007-02-20 |
2008-08-28 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the beta-2-microglobulin gene and uses thereof
|
|
US20090004715A1
(en)
|
2007-06-01 |
2009-01-01 |
Solazyme, Inc. |
Glycerol Feedstock Utilization for Oil-Based Fuel Manufacturing
|
|
PL2602323T3
(pl)
|
2007-06-01 |
2018-06-29 |
Open Monoclonal Technology, Inc. |
Kompozycje i sposoby hamowania endogennych genów immunoglobin i wytwarzania transgenicznych ludzkich przeciwciał typu idiotypowego
|
|
EP2183381A1
(en)
*
|
2007-06-01 |
2010-05-12 |
Buelow Research Enterprises Llc |
Compositions and methods for producing antibodies having human idiotypes in transgenic birds
|
|
BRPI0812233B1
(pt)
|
2007-06-05 |
2022-10-04 |
Bayer Cropscience Ag |
Processos para troca de uma sequência de dna-alvo no genoma de uma célula de planta ou planta por uma sequência de dna de interesse, e vetor de dna
|
|
EP2770052A1
(en)
|
2007-06-06 |
2014-08-27 |
Cellectis |
Method for enhancing the cleavage activity of I-CreI derived meganucleases
|
|
EP2167666A2
(en)
|
2007-06-29 |
2010-03-31 |
Pioneer Hi-Bred International Inc. |
Methods for altering the genome of a monocot plant cell
|
|
WO2009013559A1
(en)
*
|
2007-07-23 |
2009-01-29 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
|
|
WO2009019528A1
(en)
*
|
2007-08-03 |
2009-02-12 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof
|
|
US8563314B2
(en)
|
2007-09-27 |
2013-10-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating PD1
|
|
US11235026B2
(en)
|
2007-09-27 |
2022-02-01 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating PD1
|
|
EP2188384B1
(en)
*
|
2007-09-27 |
2015-07-15 |
Sangamo BioSciences, Inc. |
Rapid in vivo identification of biologically active nucleases
|
|
EP2215223B1
(en)
*
|
2007-10-31 |
2013-05-01 |
Precision Biosciences, Inc. |
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
|
|
JP2011505809A
(ja)
*
|
2007-12-07 |
2011-03-03 |
プレシジョン バイオサイエンシズ，インク． |
ヒトゲノムのＤＮａｓｅ高感受性領域に見出される認識配列を有する合理的に設計されたメガヌクレアーゼ
|
|
WO2009074842A1
(en)
*
|
2007-12-13 |
2009-06-18 |
Cellectis |
Improved chimeric meganuclease enzymes and uses thereof
|
|
MX341747B
(es)
|
2008-02-29 |
2016-08-31 |
Monsanto Technology Llc |
Evento de maiz mon87460 y composiciones y metodos para detectarlo.
|
|
WO2009114321A2
(en)
*
|
2008-03-11 |
2009-09-17 |
Precision Biosciencs, Inc. |
Rationally-designed meganucleases for maize genome engineering
|
|
US20100071083A1
(en)
*
|
2008-03-12 |
2010-03-18 |
Smith James J |
Temperature-dependent meganuclease activity
|
|
WO2009146179A1
(en)
*
|
2008-04-15 |
2009-12-03 |
University Of Iowa Research Foundation |
Zinc finger nuclease for the cftr gene and methods of use thereof
|
|
CA2722797A1
(en)
*
|
2008-04-28 |
2009-11-05 |
Precision Biosciences, Inc. |
Fusion molecules of rationally-designed dna-binding proteins and effector domains
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
EP2313498B1
(en)
|
2008-07-14 |
2017-03-15 |
Precision Biosciences, Inc. |
Recognition sequences for i-crei-derived meganucleases and uses thereof
|
|
CN102177235A
(zh)
*
|
2008-09-08 |
2011-09-07 |
赛莱克蒂斯公司 |
切割来自谷氨酰胺合成酶基因的dna靶序列的大范围核酸酶变体及其用途
|
|
EP2180058A1
(en)
*
|
2008-10-23 |
2010-04-28 |
Cellectis |
Meganuclease recombination system
|
|
AU2009319722B2
(en)
*
|
2008-11-28 |
2016-08-04 |
Corbion Biotech, Inc. |
Production of tailored oils in heterotrophic microorganisms
|
|
US20110023141A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved with parkinson's disease
|
|
US20110023150A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of genes associated with schizophrenia in animals
|
|
US20110023154A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Silkworm genome editing with zinc finger nucleases
|
|
US20110023145A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in autism spectrum disorders
|
|
US20110030072A1
(en)
*
|
2008-12-04 |
2011-02-03 |
Sigma-Aldrich Co. |
Genome editing of immunodeficiency genes in animals
|
|
US20110023152A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of cognition related genes in animals
|
|
US20110023140A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Rabbit genome editing with zinc finger nucleases
|
|
US20110023144A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in amyotrophyic lateral sclerosis disease
|
|
US20110023143A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of neurodevelopmental genes in animals
|
|
US20110023139A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in cardiovascular disease
|
|
US20110016546A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Porcine genome editing with zinc finger nucleases
|
|
US20110023148A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of addiction-related genes in animals
|
|
US20110016540A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of genes associated with trinucleotide repeat expansion disorders in animals
|
|
US20110023147A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of prion disorder-related genes in animals
|
|
US20110023151A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of abc transporters
|
|
US20110023156A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Feline genome editing with zinc finger nucleases
|
|
US20110023149A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in tumor suppression in animals
|
|
US20110023153A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in alzheimer's disease
|
|
US20110016539A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of neurotransmission-related genes in animals
|
|
US20110023146A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in secretase-associated disorders
|
|
US20110016543A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in inflammation
|
|
US20110016541A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of sensory-related genes in animals
|
|
US20110023158A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Bovine genome editing with zinc finger nucleases
|
|
US12612435B2
(en)
|
2009-01-12 |
2026-04-28 |
Ulla Bonas |
Modular DNA-binding domains and methods of use
|
|
EP2206723A1
(en)
|
2009-01-12 |
2010-07-14 |
Bonas, Ulla |
Modular DNA-binding domains
|
|
US20110239315A1
(en)
|
2009-01-12 |
2011-09-29 |
Ulla Bonas |
Modular dna-binding domains and methods of use
|
|
WO2010093966A2
(en)
*
|
2009-02-12 |
2010-08-19 |
Fred Hutchinson Cancer Research Center |
Generation of a dna nicking enzyme that stimulates site-specific gene conversion from a homing endonuclease
|
|
EP2408921B1
(en)
|
2009-03-20 |
2017-04-19 |
Sangamo BioSciences, Inc. |
Modification of cxcr4 using engineered zinc finger proteins
|
|
WO2010122367A2
(en)
*
|
2009-04-21 |
2010-10-28 |
Cellectis |
Meganuclease variants cleaving the genomic insertion of a virus and uses thereof
|
|
US8772008B2
(en)
|
2009-05-18 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing nuclease activity
|
|
WO2010136841A2
(en)
*
|
2009-05-26 |
2010-12-02 |
Cellectis |
Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof
|
|
US20120171191A1
(en)
*
|
2009-05-26 |
2012-07-05 |
Cellectis |
Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
|
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
|
EP2449135B1
(en)
|
2009-06-30 |
2016-01-06 |
Sangamo BioSciences, Inc. |
Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
|
|
WO2011007193A1
(en)
|
2009-07-17 |
2011-01-20 |
Cellectis |
Viral vectors encoding a dna repair matrix and containing a virion-associated site specific meganuclease for gene targeting
|
|
CA2769262C
(en)
|
2009-07-28 |
2019-04-30 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating trinucleotide repeat disorders
|
|
JP5940977B2
(ja)
|
2009-08-11 |
2016-06-29 |
サンガモ バイオサイエンシーズ， インコーポレイテッド |
標的改変によるホモ接合生物
|
|
US8586526B2
(en)
|
2010-05-17 |
2013-11-19 |
Sangamo Biosciences, Inc. |
DNA-binding proteins and uses thereof
|
|
WO2011021062A1
(en)
|
2009-08-21 |
2011-02-24 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human lysosomal acid alpha-glucosidase gene and uses thereof
|
|
EP2480659A2
(en)
|
2009-09-24 |
2012-08-01 |
Cellectis |
Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations
|
|
US20130074220A1
(en)
|
2009-10-26 |
2013-03-21 |
National Institute Of Agrobiological Sciences |
Method for producing genetically modified plant cell
|
|
WO2011072246A2
(en)
|
2009-12-10 |
2011-06-16 |
Regents Of The University Of Minnesota |
Tal effector-mediated dna modification
|
|
WO2011082310A2
(en)
|
2009-12-30 |
2011-07-07 |
Pioneer Hi-Bred International, Inc. |
Methods and compositions for targeted polynucleotide modification
|
|
US20120329067A1
(en)
*
|
2010-01-22 |
2012-12-27 |
Barbas Iii Carlos F |
Methods of Generating Zinc Finger Nucleases Having Altered Activity
|
|
WO2011095475A1
(en)
|
2010-02-02 |
2011-08-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the diagnosis and therapy of retinitis pigmentosa
|
|
SMT202600080T1
(it)
|
2010-02-08 |
2026-03-09 |
Regeneron Pharma |
Topo con catena leggera comune
|
|
US9796788B2
(en)
|
2010-02-08 |
2017-10-24 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing a limited immunoglobulin light chain repertoire
|
|
US20130045492A1
(en)
|
2010-02-08 |
2013-02-21 |
Regeneron Pharmaceuticals, Inc. |
Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
|
|
WO2011101696A1
(en)
|
2010-02-18 |
2011-08-25 |
Cellectis |
Improved meganuclease recombination system
|
|
WO2011104382A1
(en)
|
2010-02-26 |
2011-09-01 |
Cellectis |
Use of endonucleases for inserting transgenes into safe harbor loci
|
|
CA2794037A1
(en)
|
2010-03-22 |
2011-09-29 |
Philip Morris Products S.A. |
Modifying enzyme activity in plants
|
|
US9546369B2
(en)
|
2010-04-23 |
2017-01-17 |
University Of Massachusetts |
Multicistronic expression constructs
|
|
EP2561073B1
(en)
|
2010-04-23 |
2016-08-24 |
University of Massachusetts |
Cns targeting aav vectors and methods of use thereof
|
|
EP3444346B1
(en)
|
2010-04-23 |
2022-07-27 |
University of Massachusetts |
Aav-based treatment of cholesterol-related disorders
|
|
CA2799095A1
(en)
|
2010-05-12 |
2011-11-17 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof
|
|
US20130183282A1
(en)
|
2010-05-12 |
2013-07-18 |
Cellectis |
Meganuclease variants cleaving a DNA target sequence from the rhodopsin gene and uses thereof
|
|
US8592188B2
(en)
|
2010-05-28 |
2013-11-26 |
Solazyme, Inc. |
Tailored oils produced from recombinant heterotrophic microorganisms
|
|
US20140148361A1
(en)
*
|
2010-06-07 |
2014-05-29 |
Barry L. Stoddard |
Generation and Expression of Engineered I-ONUI Endonuclease and Its Homologues and Uses Thereof
|
|
US9593317B2
(en)
|
2010-06-09 |
2017-03-14 |
Bayer Cropscience Nv |
Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
|
|
CN109504700A
(zh)
|
2010-06-09 |
2019-03-22 |
拜尔作物科学公司 |
植物基因组改造中常用的在核苷酸序列上修饰植物基因组的方法和工具
|
|
GB201009732D0
(en)
|
2010-06-10 |
2010-07-21 |
Gene Bridges Gmbh |
Direct cloning
|
|
SG186372A1
(en)
|
2010-06-15 |
2013-01-30 |
Cellectis |
Method for improving cleavage of dna by endonuclease sensitive to methylation
|
|
US20130189759A1
(en)
|
2010-07-07 |
2013-07-25 |
Cellectis |
Meganucleases variants cleaving a dna target sequence in the nanog gene and uses thereof
|
|
WO2012010976A2
(en)
|
2010-07-15 |
2012-01-26 |
Cellectis |
Meganuclease variants cleaving a dna target sequence in the tert gene and uses thereof
|
|
WO2012007848A2
(en)
|
2010-07-16 |
2012-01-19 |
Cellectis |
Meganuclease variants cleaving a dna target sequence in the was gene and uses thereof
|
|
EP2412806B1
(en)
*
|
2010-07-28 |
2014-01-08 |
Institut Pasteur |
Use of terminal deoxynucleotidyl transferase for mutagenic DNA repair to generate variability, at a determined position in DNA
|
|
BR112013003135A2
(pt)
|
2010-08-13 |
2017-11-07 |
Pioneer Hi Bred Int |
polinucletídeo e polipeptídeo isolado ou recombinante, construto de ácido nucleico, célula, planta, explante vegetal, semente transgênica, método para produção de célula vegetal para controle de plantas daninhas e para detecção de um polipeptídeo hppd e um polinucleotídeo.
|
|
US20130337454A1
(en)
|
2010-10-27 |
2013-12-19 |
Philippe Duchateau |
Method for increasing the efficiency of double-strand break-induced mutagenesis
|
|
EP2635663B1
(en)
|
2010-11-03 |
2019-05-08 |
Corbion Biotech, Inc. |
Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
|
|
KR101964965B1
(ko)
|
2011-02-02 |
2019-04-03 |
테라비아 홀딩스 인코포레이티드 |
재조합 유지성 미생물로부터 생산된 맞춤 오일
|
|
US9044492B2
(en)
|
2011-02-04 |
2015-06-02 |
Cellectis Sa |
Method for modulating the efficiency of double-strand break-induced mutagenesis
|
|
AR085302A1
(es)
|
2011-02-24 |
2013-09-18 |
Sanofi Sa |
Metodo de produccion de anticuerpos sialilados
|
|
US8673557B2
(en)
|
2011-02-28 |
2014-03-18 |
Seattle Children's Research Institute |
Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
|
|
CA2831144A1
(en)
|
2011-03-23 |
2012-09-27 |
Pioneer Hi-Bred International, Inc. |
Methods for producing a complex transgenic trait locus
|
|
WO2012138901A1
(en)
|
2011-04-05 |
2012-10-11 |
Cellectis Sa |
Method for enhancing rare-cutting endonuclease efficiency and uses thereof
|
|
CA3111953C
(en)
|
2011-04-05 |
2023-10-24 |
Cellectis |
Method for the generation of compact tale-nucleases and uses thereof
|
|
EP3318635A1
(en)
|
2011-04-21 |
2018-05-09 |
University of Massachusetts |
Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
|
|
AU2012249390B2
(en)
|
2011-04-27 |
2017-03-30 |
Amyris, Inc. |
Methods for genomic modification
|
|
US9708672B2
(en)
|
2011-05-02 |
2017-07-18 |
Nutech Ventures |
Plants with useful traits and related methods
|
|
MX339607B
(es)
|
2011-05-06 |
2016-05-31 |
Solazyme Inc |
Microorganismos geneticamente modificados que metabolizan xilosa.
|
|
WO2012158778A1
(en)
|
2011-05-16 |
2012-11-22 |
Cellectis S.A. |
Doubly secure transgenic algae or cyanobacteria strains to prevent their establishment and spread in natural ecosystems
|
|
EP2714936B1
(en)
*
|
2011-06-01 |
2018-12-12 |
Precision Biosciences, Inc. |
Methods and products for producing engineered mammalian cell lines with amplified transgenes
|
|
EP2729567B1
(en)
|
2011-07-08 |
2016-10-05 |
Cellectis |
Method for increasing the efficiency of double-strand break-induced mutagenssis
|
|
US9161995B2
(en)
*
|
2011-07-25 |
2015-10-20 |
Sangamo Biosciences, Inc. |
Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
|
|
HUE047278T2
(hu)
|
2011-08-05 |
2020-04-28 |
Regeneron Pharma |
Humanizált univerzális könnyûláncú egerek
|
|
BR112014003919A2
(pt)
|
2011-08-22 |
2017-03-14 |
Bayer Cropscience Ag |
métodos e meios para modificar um genoma de planta
|
|
WO2013053730A1
(en)
|
2011-10-12 |
2013-04-18 |
Bayer Cropscience Ag |
Plants with decreased activity of a starch dephosphorylating enzyme
|
|
BR112014008895A2
(pt)
|
2011-10-12 |
2019-09-24 |
Bayer Cropscience Ag |
plantas com atividade diminuída de uma enzima de desfosforilação do amido
|
|
CA3099582A1
(en)
*
|
2011-10-27 |
2013-05-02 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of the hprt locus
|
|
WO2013103366A1
(en)
|
2012-01-06 |
2013-07-11 |
Pioneer Hi-Bred International, Inc. |
A method to screen plants for genetic elements inducing parthenogenesis in plants
|
|
US20150166969A1
(en)
|
2012-02-24 |
2015-06-18 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for the treatment of hemoglobinopathies
|
|
WO2013130824A1
(en)
|
2012-02-29 |
2013-09-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating huntington's disease
|
|
DK2825190T3
(en)
|
2012-03-15 |
2017-02-27 |
Cellectis |
REPEAT VARIABLE DIRESTS FOR TARGETING NUCLEOTIDES
|
|
SG11201405956SA
(en)
|
2012-03-23 |
2014-11-27 |
Cellectis |
Method to overcome dna chemical modifications sensitivity of engineered tale dna binding domains
|
|
US9719114B2
(en)
|
2012-04-18 |
2017-08-01 |
Terravia Holdings, Inc. |
Tailored oils
|
|
US8945908B2
(en)
|
2012-04-18 |
2015-02-03 |
Solazyme, Inc. |
Tailored oils
|
|
CN104245940A
(zh)
|
2012-04-23 |
2014-12-24 |
拜尔作物科学公司 |
植物中的靶向基因组工程
|
|
US20150017136A1
(en)
|
2013-07-15 |
2015-01-15 |
Cellectis |
Methods for engineering allogeneic and highly active t cell for immunotherapy
|
|
BR112014029417B1
(pt)
|
2012-05-25 |
2023-03-07 |
Cellectis |
Método ex vivo para a preparação de células t para imunoterapia
|
|
WO2013182910A2
(en)
|
2012-06-05 |
2013-12-12 |
Cellectis |
New transcription activator-like effector (tale) fusion protein
|
|
US20150225734A1
(en)
|
2012-06-19 |
2015-08-13 |
Regents Of The University Of Minnesota |
Gene targeting in plants using dna viruses
|
|
US10648001B2
(en)
*
|
2012-07-11 |
2020-05-12 |
Sangamo Therapeutics, Inc. |
Method of treating mucopolysaccharidosis type I or II
|
|
EP3196301B1
(en)
|
2012-07-11 |
2018-10-17 |
Sangamo Therapeutics, Inc. |
Methods and compositions for the treatment of monogenic diseases
|
|
EP2877488B1
(en)
|
2012-07-24 |
2021-02-24 |
Cellectis |
New modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins
|
|
JP6164696B2
(ja)
*
|
2012-08-16 |
2017-07-19 |
公立大学法人横浜市立大学 |
ミトコンドリア複合体ｉｉｉ欠乏症患者又は保因者の検出方法
|
|
US10378007B2
(en)
|
2012-09-03 |
2019-08-13 |
Cellectis |
Methods for modulating TAL specificity
|
|
MX367730B
(es)
|
2012-09-04 |
2019-09-04 |
Cellectis |
Receptor de antigeno quimerico multi-cadena y usos del mismo.
|
|
AU2013329186B2
(en)
|
2012-10-10 |
2019-02-14 |
Sangamo Therapeutics, Inc. |
T cell modifying compounds and uses thereof
|
|
CA2890160A1
(en)
|
2012-10-31 |
2014-05-08 |
Cellectis |
Coupling herbicide resistance with targeted insertion of transgenes in plants
|
|
JP6450683B2
(ja)
|
2012-11-01 |
2019-01-09 |
セレクティス |
治療用タンパク質の生産のための植物
|
|
WO2014083379A1
(en)
|
2012-11-30 |
2014-06-05 |
Institut Pasteur |
Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shock
|
|
US10513698B2
(en)
|
2012-12-21 |
2019-12-24 |
Cellectis |
Potatoes with reduced cold-induced sweetening
|
|
ES2953523T3
(es)
|
2012-12-27 |
2023-11-14 |
Keygene Nv |
Método para inducir una translocación dirigida en una planta
|
|
US9528011B2
(en)
|
2013-01-11 |
2016-12-27 |
Ceraloc Innovation Ab |
Digital binder and powder print
|
|
EP2951295B1
(en)
|
2013-02-01 |
2018-08-01 |
Cellectis |
Tevi chimeric endonucleases and their preferential cleavage sites
|
|
US20150353885A1
(en)
|
2013-02-21 |
2015-12-10 |
Cellectis |
Method to counter-select cells or organisms by linking loci to nuclease components
|
|
EP2970923B1
(en)
|
2013-03-13 |
2018-04-11 |
President and Fellows of Harvard College |
Mutants of cre recombinase
|
|
EP2966983B1
(en)
|
2013-03-15 |
2021-07-28 |
Cellectis |
Modifying soybean oil composition through targeted knockout of the fad2-1a/1b genes
|
|
US10113162B2
(en)
*
|
2013-03-15 |
2018-10-30 |
Cellectis |
Modifying soybean oil composition through targeted knockout of the FAD2-1A/1B genes
|
|
AU2014266833B2
(en)
|
2013-05-13 |
2020-07-02 |
Cellectis |
Methods for engineering highly active T cell for immunotherapy
|
|
JP2016521561A
(ja)
|
2013-06-14 |
2016-07-25 |
セレクティス |
植物における非トランスジェニックのゲノム編集のための方法
|
|
CN120574876A
(zh)
|
2013-08-22 |
2025-09-02 |
纳幕尔杜邦公司 |
使用向导rna/cas内切核酸酶系统的植物基因组修饰及其使用方法
|
|
US10767188B2
(en)
|
2013-09-25 |
2020-09-08 |
Nutech Ventures |
Methods and compositions for obtaining useful plant traits
|
|
MX369685B
(es)
|
2013-10-04 |
2019-11-19 |
Terravia Holdings Inc |
Aceites adaptables.
|
|
CA2927965A1
(en)
|
2013-10-25 |
2015-04-30 |
Cellectis |
Design of rare-cutting endonucleases for efficient and specific targeting dna sequences comprising highly repetitive motives
|
|
WO2015070212A1
(en)
|
2013-11-11 |
2015-05-14 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating huntington's disease
|
|
EP3083958B1
(en)
|
2013-12-19 |
2019-04-17 |
Amyris, Inc. |
Methods for genomic integration
|
|
NZ759969A
(en)
|
2013-12-20 |
2022-12-23 |
Fred Hutchinson Cancer Center |
Tagged chimeric effector molecules and receptors thereof
|
|
EP4659765A3
(en)
*
|
2014-03-12 |
2026-02-18 |
Precision Biosciences, Inc. |
Dystrophin gene exon deletion using engineered nucleases
|
|
CN106459894B
(zh)
|
2014-03-18 |
2020-02-18 |
桑格摩生物科学股份有限公司 |
用于调控锌指蛋白表达的方法和组合物
|
|
CA2942515C
(en)
|
2014-03-18 |
2025-12-09 |
University Of Massachusetts |
Raav-based compositions and methods for treating amyotrophic lateral sclerosis
|
|
BR112016019940A2
(pt)
|
2014-03-21 |
2017-10-24 |
Univ Leland Stanford Junior |
edição de genoma sem nucleases
|
|
CA3124228C
(en)
|
2014-03-21 |
2024-05-14 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals that make single domain binding proteins
|
|
WO2015187825A2
(en)
|
2014-06-03 |
2015-12-10 |
University Of Massachusetts |
Compositions and methods for modulating dysferlin expression
|
|
CA2952906A1
(en)
|
2014-06-20 |
2015-12-23 |
Cellectis |
Potatoes with reduced granule-bound starch synthase
|
|
US9969990B2
(en)
|
2014-07-10 |
2018-05-15 |
Corbion Biotech, Inc. |
Ketoacyl ACP synthase genes and uses thereof
|
|
EP3200830B1
(en)
|
2014-10-03 |
2020-09-09 |
University of Massachusetts |
High efficiency library-identified aav vectors
|
|
US10370432B2
(en)
|
2014-10-03 |
2019-08-06 |
University Of Massachusetts |
Heterologous targeting peptide grafted AAVS
|
|
CN107073051B
(zh)
|
2014-10-21 |
2021-08-24 |
马萨诸塞大学 |
重组aav变体及其用途
|
|
ES2870983T3
(es)
|
2014-12-19 |
2021-10-28 |
Univ Nantes |
Anticuerpos anti-IL-34
|
|
EP3253877A1
(en)
|
2015-02-02 |
2017-12-13 |
Cellectis |
Agrobacterium-mediated genome modification without t-dna integration
|
|
EP3256170B1
(en)
|
2015-02-13 |
2020-09-23 |
University of Massachusetts |
Compositions and methods for transient delivery of nucleases
|
|
CA2979702A1
(en)
|
2015-03-19 |
2016-09-22 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals that select for light chain variable regions that bind antigen
|
|
EP3274453B1
(en)
*
|
2015-03-26 |
2021-01-27 |
Editas Medicine, Inc. |
Crispr/cas-mediated gene conversion
|
|
CA2981077A1
(en)
|
2015-04-03 |
2016-10-06 |
Dana-Farber Cancer Institute, Inc. |
Composition and methods of genome editing of b-cells
|
|
US11046955B2
(en)
|
2015-04-24 |
2021-06-29 |
University Of Massachusetts |
Modified AAV constructs and uses thereof
|
|
EP3288570A4
(en)
|
2015-04-29 |
2018-11-21 |
Fred Hutchinson Cancer Research Center |
Modified stem cells and uses thereof
|
|
ES2905181T3
(es)
|
2015-05-01 |
2022-04-07 |
Prec Biosciences Inc |
Deleción precisa de secuencias cromosómicas in vivo
|
|
WO2016178207A1
(en)
|
2015-05-04 |
2016-11-10 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for fragmenting dna
|
|
CA2985650A1
(en)
|
2015-05-13 |
2016-11-17 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Enhancing endonuclease based gene editing in primary cells
|
|
EP3316676A4
(en)
|
2015-06-30 |
2018-12-12 |
Regents of the University of Minnesota |
Haploid inducer line for accelerated genome editing
|
|
CA2997535A1
(en)
|
2015-07-23 |
2017-01-26 |
Mayo Foundation For Medical Education And Research |
Editing mitochondrial dna
|
|
JP6713691B2
(ja)
*
|
2015-08-20 |
2020-07-01 |
大学共同利用機関法人情報・システム研究機構 |
動物細胞ゲノム部位特異的外来ｄｎａ挿入方法及び前記挿入方法を用いて得られる細胞
|
|
US10837024B2
(en)
|
2015-09-17 |
2020-11-17 |
Cellectis |
Modifying messenger RNA stability in plant transformations
|
|
WO2017070516A1
(en)
|
2015-10-22 |
2017-04-27 |
University Of Massachusetts |
Prostate-targeting adeno-associated virus serotype vectors
|
|
EP3364997B1
(en)
|
2015-10-22 |
2024-01-17 |
University of Massachusetts |
Aspartoacylase gene therapy in the treatment of canavan disease
|
|
WO2017079428A1
(en)
|
2015-11-04 |
2017-05-11 |
President And Fellows Of Harvard College |
Site specific germline modification
|
|
BR112018012235A2
(pt)
|
2015-12-18 |
2018-12-04 |
Sangamo Therapeutics Inc |
rompimento alvejado do receptor de células de mhc
|
|
EP3389677B1
(en)
|
2015-12-18 |
2024-06-26 |
Sangamo Therapeutics, Inc. |
Targeted disruption of the t cell receptor
|
|
IL260532B2
(en)
|
2016-01-11 |
2023-12-01 |
Univ Leland Stanford Junior |
Chimeric proteins- containing systems and uses thereof in regulating gene expression
|
|
MX2018008345A
(es)
|
2016-01-11 |
2018-12-06 |
Univ Leland Stanford Junior |
Proteínas quiméricas y métodos de inmunoterapia.
|
|
WO2017134601A1
(en)
|
2016-02-02 |
2017-08-10 |
Cellectis |
Modifying soybean oil composition through targeted knockout of the fad3a/b/c genes
|
|
CA3011939A1
(en)
|
2016-02-02 |
2017-08-10 |
University Of Massachusetts |
Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
|
|
CA3012344A1
(en)
|
2016-02-12 |
2017-08-17 |
University Of Massachusetts |
Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization
|
|
US20190032088A1
(en)
|
2016-02-26 |
2019-01-31 |
Cellectis |
Micelle based system nuclease encapsulation for in-vivo gene editing
|
|
WO2017153432A1
(en)
|
2016-03-07 |
2017-09-14 |
Pierre Fabre Medicament |
A new universal method to capture and analyze adcs for characterization of drug distribution and the drug-to-antibody ratio in biological samples
|
|
US11207426B2
(en)
|
2016-04-05 |
2021-12-28 |
University Of Massachusetts |
Compositions and methods for selective inhibition of grainyhead-like protein expression
|
|
US11773410B2
(en)
*
|
2016-04-13 |
2023-10-03 |
University Of Massachusetts |
Repairing compound heterozygous recessive mutations by allele exchange
|
|
US11413356B2
(en)
|
2016-04-15 |
2022-08-16 |
University Of Massachusetts |
Methods and compositions for treating metabolic imbalance
|
|
DK3452583T3
(da)
|
2016-05-03 |
2022-01-10 |
Prec Biosciences Inc |
Konstruerede nukleaser, der er nyttige til behandling af hæmofili a
|
|
US11293033B2
(en)
|
2016-05-18 |
2022-04-05 |
Amyris, Inc. |
Compositions and methods for genomic integration of nucleic acids into exogenous landing pads
|
|
AU2017271575A1
(en)
|
2016-05-25 |
2018-11-15 |
Pioneer Hi-Bred International, Inc. |
Engineered nucleases to generate deletion mutants in plants
|
|
PL3464333T3
(pl)
|
2016-05-26 |
2024-09-30 |
Nunhems B.V. |
Rośliny wytwarzające bezpestkowe owoce
|
|
KR102483193B1
(ko)
|
2016-06-03 |
2023-01-04 |
리제너론 파마슈티칼스 인코포레이티드 |
외인성 말단 데옥시뉴클레오타이드 전달효소를 발현하는 비인간 동물
|
|
US11882815B2
(en)
|
2016-06-15 |
2024-01-30 |
University Of Massachusetts |
Recombinant adeno-associated viruses for delivering gene editing molecules to embryonic cells
|
|
WO2018005589A1
(en)
|
2016-06-28 |
2018-01-04 |
Cellectis |
Altering expression of gene products in plants through targeted insertion of nucleic acid sequences
|
|
AU2017291851B2
(en)
|
2016-07-06 |
2022-10-13 |
Cellectis |
Sequential gene editing in primary immune cells
|
|
MA45996A
(fr)
*
|
2016-08-16 |
2021-06-02 |
Bluebird Bio Inc |
Variants d'endonucléase de homing du récepteur alpha de l'il-10, compositions et méthodes d'utilisation associées
|
|
CA3034271A1
(en)
|
2016-08-18 |
2018-02-22 |
Cellectis |
Black-spot resistant potatoes with reduced tuber-specific polyphenol oxidase activity
|
|
KR102455249B1
(ko)
|
2016-08-24 |
2022-10-17 |
상가모 테라퓨틱스, 인코포레이티드 |
가공된 표적 특이적 뉴클레아제
|
|
WO2018042346A2
(en)
|
2016-09-01 |
2018-03-08 |
Cellectis |
Methods for altering amino acid content in plants
|
|
US10457940B2
(en)
|
2016-09-22 |
2019-10-29 |
University Of Massachusetts |
AAV treatment of Huntington's disease
|
|
CN109996868A
(zh)
|
2016-09-23 |
2019-07-09 |
弗雷德哈钦森癌症研究中心 |
特异性用于次要组织相容性(h)抗原ha-1的tcr及其用途
|
|
US20190225974A1
(en)
|
2016-09-23 |
2019-07-25 |
BASF Agricultural Solutions Seed US LLC |
Targeted genome optimization in plants
|
|
AU2017341849B2
(en)
|
2016-10-13 |
2024-03-21 |
University Of Massachusetts |
AAV capsid designs
|
|
WO2018073391A1
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Targeted gene insertion for improved immune cells therapy
|
|
CA3042857A1
(en)
|
2016-11-16 |
2018-05-24 |
Cellectis |
Methods for altering amino acid content in plants through frameshift mutations
|
|
US11192929B2
(en)
|
2016-12-08 |
2021-12-07 |
Regents Of The University Of Minnesota |
Site-specific DNA base editing using modified APOBEC enzymes
|
|
WO2018115189A1
(en)
|
2016-12-21 |
2018-06-28 |
Cellectis |
Stably enginereed proteasome inhibitor resistant immune cells for immunotherapy
|
|
IL268049B2
(en)
|
2017-01-19 |
2025-08-01 |
Omniab Inc |
Transgenic rodent human antibodies with multiple immunoglobulin heavy chain loci
|
|
JP7037577B2
(ja)
|
2017-03-15 |
2022-03-16 |
フレッド ハッチンソン キャンサー リサーチ センター |
高親和性ｍａｇｅ－ａ１特異的ｔｃｒ及びその使用
|
|
WO2018189360A1
(en)
|
2017-04-13 |
2018-10-18 |
Cellectis |
New sequence specific reagents targeting ccr5 in primary hematopoietic cells
|
|
EP3392339A1
(en)
|
2017-04-18 |
2018-10-24 |
Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen |
Improved genome editing in plant cells
|
|
IL301059B2
(en)
*
|
2017-04-21 |
2026-04-01 |
Prec Biosciences Inc |
Engineered nucleosides specific for recognition sequences in the PCSK9 gene
|
|
CA3060622A1
(en)
|
2017-04-25 |
2018-11-01 |
Cellectis |
Alfalfa with reduced lignin composition
|
|
CN110799492B
(zh)
|
2017-04-28 |
2023-06-27 |
爱康泰生治疗公司 |
用于递送核酸的新型羰基脂质和脂质纳米颗粒制剂
|
|
US11655275B2
(en)
|
2017-05-03 |
2023-05-23 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
|
|
US11859179B2
(en)
|
2017-05-09 |
2024-01-02 |
University Of Massachusetts |
Methods of treating amyotrophic lateral sclerosis (ALS)
|
|
WO2018206791A1
(en)
|
2017-05-12 |
2018-11-15 |
Cellectis |
Protease based switch chimeric antigen receptors for safer cell immunotherapy
|
|
CA3064000A1
(en)
|
2017-05-24 |
2018-11-29 |
Effector Therapeutics, Inc. |
Methods and compositions for cellular immunotherapy
|
|
MA48797A
(fr)
|
2017-05-25 |
2020-04-08 |
Bluebird Bio Inc |
Variants de l'endonucléase cblb , compositions et procédés d'utilisation
|
|
US20210139870A1
(en)
|
2017-06-19 |
2021-05-13 |
Cellectis |
Anti-hbv combination therapies involving specific endonucleases
|
|
US11332749B2
(en)
|
2017-07-13 |
2022-05-17 |
Regents Of The University Of Minnesota |
Real-time reporter systems for monitoring base editing
|
|
WO2019016360A1
(en)
|
2017-07-21 |
2019-01-24 |
Cellectis |
MODIFIED IMMUNE CELLS RESISTANT TO TUMOR MICRO-ENVIRONMENT
|
|
US12398191B2
(en)
|
2017-08-11 |
2025-08-26 |
Fred Hutchinson Cancer Center |
BRAF-specific TCRs and uses thereof
|
|
US12350312B2
(en)
|
2017-09-06 |
2025-07-08 |
Fred Hutchinson Cancer Center |
Methods for improving adoptive cell therapy
|
|
CN111051349A
(zh)
|
2017-09-06 |
2020-04-21 |
弗雷德哈钦森癌症研究中心 |
Strep-tag特异性嵌合受体及其用途
|
|
CN111448321A
(zh)
|
2017-09-22 |
2020-07-24 |
马萨诸塞大学 |
Sod1双表达载体及其用途
|
|
KR20200075851A
(ko)
|
2017-10-19 |
2020-06-26 |
셀렉티스 |
개선된 면역 세포들 치료를 위한 nk 억제제들의 타겟인 유전자 통합
|
|
US20210069241A1
(en)
|
2017-10-20 |
2021-03-11 |
Fred Hutchinson Cancer Research Center |
Compositions and methods of immunotherapy targeting tigit and/or cd112r or comprising cd226 overexpression
|
|
WO2019089913A1
(en)
*
|
2017-11-01 |
2019-05-09 |
Precision Biosciences, Inc. |
Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
|
|
US20220267403A1
(en)
|
2017-12-01 |
2022-08-25 |
Fred Hutchinson Cancer Research Center |
Binding proteins specific for 5t4 and uses thereof
|
|
WO2019106163A1
(en)
|
2017-12-01 |
2019-06-06 |
Cellectis |
Reprogramming of genetically engineered primary immune cells
|
|
WO2019110662A1
(en)
|
2017-12-05 |
2019-06-13 |
Progastrine Et Cancers S.À R.L. |
Combination therapy between anti-progastrin antibody and immunotherapy to treat cancer
|
|
WO2019129850A1
(en)
|
2017-12-29 |
2019-07-04 |
Cellectis |
Off-the-shelf engineered cells for therapy
|
|
WO2019140278A1
(en)
|
2018-01-11 |
2019-07-18 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting core binding factor antigens
|
|
AU2019207409B2
(en)
|
2018-01-12 |
2023-02-23 |
Basf Se |
Gene underlying the number of spikelets per spike qtl in wheat on chromosome 7a
|
|
AU2019224051A1
(en)
|
2018-02-26 |
2020-09-03 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
EP3759492A1
(en)
|
2018-02-27 |
2021-01-06 |
ECS-Progastrin SA |
Progastrin as a biomarker for immunotherapy
|
|
EP3781677A4
(en)
|
2018-04-16 |
2022-01-19 |
University of Massachusetts |
COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITTING
|
|
CA3234120A1
(en)
|
2018-05-02 |
2019-11-07 |
Cellectis |
Engineering wheat with increased dietary fiber
|
|
US11690921B2
(en)
|
2018-05-18 |
2023-07-04 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
|
EP3802839A1
(en)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
|
EP3800998A1
(en)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Methods of regenerating and transforming cannabis
|
|
WO2019236995A1
(en)
|
2018-06-08 |
2019-12-12 |
University Of Massachusetts |
Antisense oligonucleotides to restore dysferlin protein expression in dysferlinopathy patient cells
|
|
DK3806903T5
(da)
|
2018-06-14 |
2024-08-19 |
2Seventy Bio Inc |
Cd79a kimæriske antigenreceptorer
|
|
EP3806619A1
(en)
|
2018-06-15 |
2021-04-21 |
Nunhems B.V. |
Seedless watermelon plants comprising modifications in an abc transporter gene
|
|
CA3105331A1
(en)
|
2018-07-09 |
2020-01-16 |
Cellectis |
Canola with high oleic acid
|
|
CN112740043A
(zh)
|
2018-07-20 |
2021-04-30 |
皮埃尔法布雷医药公司 |
Vista受体
|
|
WO2020018964A1
(en)
|
2018-07-20 |
2020-01-23 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for controlled expression of antigen-specific receptors
|
|
CN112912387A
(zh)
|
2018-08-22 |
2021-06-04 |
弗雷德哈钦森癌症研究中心 |
靶向kras或her2抗原的免疫疗法
|
|
CA3110089A1
(en)
|
2018-08-28 |
2020-03-05 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for adoptive t cell therapy incorporating induced notch signaling
|
|
KR20210060533A
(ko)
|
2018-09-18 |
2021-05-26 |
상가모 테라퓨틱스, 인코포레이티드 |
프로그램화된 세포 사멸 1 (pd1) 특이적 뉴클레아제
|
|
IL281615B2
(en)
|
2018-09-21 |
2026-01-01 |
Acuitas Therapeutics Inc |
Systems and methods for producing lipid nanoparticles and liposomes
|
|
US20240165232A1
(en)
|
2018-09-24 |
2024-05-23 |
Fred Hutchinson Cancer Research Center |
Chimeric receptor proteins and uses thereof
|
|
MX2021003580A
(es)
|
2018-09-28 |
2021-10-13 |
Pf Medicament |
Nuevas inmunocitocinas para el tratamiento contra el cancer.
|
|
WO2020072059A1
(en)
|
2018-10-04 |
2020-04-09 |
Bluebird Bio, Inc. |
Cblb endonuclease variants, compositions, and methods of use
|
|
CA3116576A1
(en)
|
2018-10-18 |
2020-04-23 |
Acuitas Therapeutics, Inc. |
Lipids for lipid nanoparticle delivery of active agents
|
|
CA3119188A1
(en)
|
2018-11-09 |
2020-05-14 |
Fred Hutchinson Cancer Research Center |
T cell receptors specific for mesothelin and their use in immunotherapy
|
|
CA3123890A1
(en)
|
2019-01-04 |
2020-07-09 |
Cargill Incorporated |
Engineered nucleases to generate mutations in plants
|
|
PT3908568T
(pt)
|
2019-01-11 |
2024-09-30 |
Acuitas Therapeutics Inc |
Lípidos para a administração de agentes ativos por nanopartículas lipídicas
|
|
WO2020159470A1
(en)
|
2019-01-28 |
2020-08-06 |
Mayo Foundation For Medical Education And Research |
Mitochondrial genome editing methods
|
|
CN114026116A
(zh)
|
2019-02-20 |
2022-02-08 |
弗雷德哈钦森癌症研究中心 |
Ras新抗原特异性结合蛋白及其用途
|
|
MX2021010559A
(es)
|
2019-03-07 |
2021-12-15 |
Univ California |
Polipéptidos efectores de crispr-cas y métodos de uso de estos.
|
|
WO2020185796A1
(en)
|
2019-03-11 |
2020-09-17 |
Fred Hutchinson Cancer Research Center |
High avidity wt1 t cell receptors and uses thereof
|
|
WO2020252455A1
(en)
|
2019-06-13 |
2020-12-17 |
The General Hospital Corporation |
Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
|
|
US20220348912A1
(en)
|
2019-06-20 |
2022-11-03 |
University Of Massachusetts |
Compositions and methods for improved gene editing
|
|
JP7737978B2
(ja)
|
2019-08-20 |
2025-09-11 |
フレッド ハッチンソン キャンサー センター |
Ｗｔ－１に特異的なｔ細胞免疫療法
|
|
US20220306736A1
(en)
|
2019-09-04 |
2022-09-29 |
Y-Biologics Inc. |
Anti-vsig4 antibody or antigen binding fragment and uses thereof
|
|
CN114423281A
(zh)
|
2019-09-20 |
2022-04-29 |
卡里克特公司 |
基于基因编辑的低植物雌激素大豆
|
|
US20230008694A1
(en)
|
2019-11-27 |
2023-01-12 |
Calyxt, Inc. |
Tal-effector nucleases for gene editing
|
|
EP4073117A1
(en)
|
2019-12-10 |
2022-10-19 |
Institut Pasteur |
New antibody blocking human fcgriiia and fcgriiib
|
|
EP4081537A1
(en)
|
2019-12-23 |
2022-11-02 |
Cellectis |
New mesothelin specific chimeric antigen receptors (car) for solid tumors cancer immunotherapy
|
|
WO2021130718A1
(en)
|
2019-12-24 |
2021-07-01 |
Selexis Sa |
Targeted integration in mammalian sequences enhancing gene expression
|
|
JP7837273B2
(ja)
|
2020-01-31 |
2026-03-30 |
サイバス オイローペ ベスローテン ヴェンノーツハップ |
ダイズにおける飽和脂肪の増加
|
|
EP3889183A1
(en)
|
2020-04-01 |
2021-10-06 |
Pierre Fabre Medicament |
A protein complex comprising an immunocytokine
|
|
CN115803435A
(zh)
|
2020-05-06 |
2023-03-14 |
塞勒克提斯公司 |
用于在细胞基因组中靶向插入外源序列的方法
|
|
EP4146284A1
(en)
|
2020-05-06 |
2023-03-15 |
Cellectis S.A. |
Methods to genetically modify cells for delivery of therapeutic proteins
|
|
US20230242900A1
(en)
*
|
2020-07-16 |
2023-08-03 |
The Texas A&M University System |
Self-eliminating transgenes
|
|
ES3054438T3
(en)
|
2020-07-16 |
2026-02-03 |
Acuitas Therapeutics Inc |
Cationic lipids for use in lipid nanoparticles
|
|
EP4185616A1
(en)
|
2020-07-24 |
2023-05-31 |
Cellectis S.A. |
T-cells expressing immune cell engagers in allogenic settings
|
|
CA3189601A1
(en)
|
2020-07-24 |
2022-01-27 |
The General Hospital Corporation |
Enhanced virus-like particles and methods of use thereof for delivery to cells
|
|
US20240011003A1
(en)
*
|
2020-08-21 |
2024-01-11 |
Precision Biosciences, Inc. |
Engineered meganucleases having specificity for a recognition sequence in the transthyretin gene
|
|
US12152251B2
(en)
|
2020-08-25 |
2024-11-26 |
Kite Pharma, Inc. |
T cells with improved functionality
|
|
WO2022066973A1
(en)
|
2020-09-24 |
2022-03-31 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting pbk or oip5 antigens
|
|
CN116724053A
(zh)
|
2020-09-24 |
2023-09-08 |
弗雷德哈钦森癌症中心 |
靶向sox2抗原的免疫治疗
|
|
US10894812B1
(en)
|
2020-09-30 |
2021-01-19 |
Alpine Roads, Inc. |
Recombinant milk proteins
|
|
AU2021353004A1
(en)
|
2020-09-30 |
2023-04-13 |
Nobell Foods, Inc. |
Recombinant milk proteins and food compositions comprising the same
|
|
US10947552B1
(en)
|
2020-09-30 |
2021-03-16 |
Alpine Roads, Inc. |
Recombinant fusion proteins for producing milk proteins in plants
|
|
WO2022076353A1
(en)
|
2020-10-06 |
2022-04-14 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for treating mage-a1-expressing disease
|
|
WO2022112596A1
(en)
|
2020-11-30 |
2022-06-02 |
Cellectis Sa |
Use of aminoquinoline compounds for higher gene integration
|
|
WO2022132836A2
(en)
|
2020-12-14 |
2022-06-23 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for cellular immunotherapy
|
|
US20240301372A1
(en)
*
|
2021-01-25 |
2024-09-12 |
Fred Hutchinson Cancer Center |
Treatment for hsv-1 using a meganuclease
|
|
EP4291663A4
(en)
|
2021-02-09 |
2025-04-02 |
The Regents Of The University Of California |
IMMUNE REGULATORS INVOLVED IN DEFENSE AGAINST PLANT DISEASES CAUSED BY LIBERIBACTER SPECIES
|
|
US20240158503A1
(en)
|
2021-03-03 |
2024-05-16 |
Pierre Fabre Medicament |
Anti-vsig4 antibody or antigen binding fragment and uses thereof
|
|
CA3212351A1
(en)
|
2021-03-12 |
2022-09-15 |
Mendus B.V. |
Methods of vaccination and use of cd47 blockade
|
|
US20240209094A1
(en)
|
2021-04-30 |
2024-06-27 |
Pierre Fabre Medicament |
New stable anti-vista antibody
|
|
US20240197880A1
(en)
|
2021-04-30 |
2024-06-20 |
Cellectis S.A. |
New anti-muc1 cars and gene edited immune cells for solid tumors cancer immunotherapy
|
|
WO2022243529A1
(en)
|
2021-05-20 |
2022-11-24 |
Cellectis S.A. |
GENE THERAPY FOR THE TREATMENT OF HYPER-IgE SYNDROME (HIES) BY TARGETED GENE INTEGRATION
|
|
AU2022278634A1
(en)
|
2021-05-20 |
2023-12-07 |
Albert-Ludwigs-Universität Freiburg |
Gene therapy for the treatment of severe combined immunodeficiency (scid) related to rag1
|
|
AU2022277649A1
(en)
|
2021-05-21 |
2023-11-30 |
Cellectis S.A. |
Enhancing efficacy of t-cell-mediated immunotherapy by modulating cancer-associated fibroblasts in solid tumors
|
|
AU2022299552A1
(en)
|
2021-06-25 |
2024-01-04 |
Oxford Biomedica (Us) Llc |
Adeno-associated virus packaging systems
|
|
TW202317602A
(zh)
|
2021-07-15 |
2023-05-01 |
福瑞德哈金森腫瘤中心 |
嵌合多肽
|
|
IL310550A
(en)
|
2021-08-04 |
2024-03-01 |
Univ Colorado Regents |
LAT-activating chimeric antigen receptor T cells and methods of using them
|
|
US20230090654A1
(en)
|
2021-08-24 |
2023-03-23 |
Homology Medicines, Inc. |
Adeno-associated virus formulations
|
|
WO2023077086A1
(en)
|
2021-10-29 |
2023-05-04 |
Homology Medicines, Inc. |
Methods and compositions for the purification of adeno-associated virus
|
|
CA3237482A1
(en)
|
2021-11-03 |
2023-05-11 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Precise genome editing using retrons
|
|
GB202117314D0
(en)
|
2021-11-30 |
2022-01-12 |
Clarke David John |
Cyclic nucleic acid fragmentation
|
|
EP4441074A2
(en)
|
2021-12-03 |
2024-10-09 |
The Broad Institute, Inc. |
Compositions and methods for efficient in vivo delivery
|
|
WO2023114897A2
(en)
|
2021-12-15 |
2023-06-22 |
Homology Medicines, Inc. |
Methods and compositions for the production of adeno-associated virus
|
|
CA3242402A1
(en)
|
2021-12-16 |
2023-06-22 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
WO2023141602A2
(en)
|
2022-01-21 |
2023-07-27 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
CN119698431A
(zh)
|
2022-05-02 |
2025-03-25 |
皮埃尔法布雷医药公司 |
新的抗vista抗体制剂
|
|
EP4276174A1
(en)
|
2022-05-09 |
2023-11-15 |
Cellectis S.A. |
Gene therapy for the treatment of activated pi3kinase delta syndrome type 1 (apds1)
|
|
CN120303407A
(zh)
|
2022-05-17 |
2025-07-11 |
恩维洛普治疗有限责任公司 |
用于有效体内递送的组合物和方法
|
|
WO2023233003A1
(en)
|
2022-06-03 |
2023-12-07 |
Cellectis Sa |
Tale base editors for gene and cell therapy
|
|
AU2023298102A1
(en)
|
2022-06-30 |
2024-11-14 |
Cellectis S.A. |
Enhancing safety of t-cell-mediated immunotherapy
|
|
WO2024044723A1
(en)
|
2022-08-25 |
2024-02-29 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
|
JP2025536578A
(ja)
|
2022-11-03 |
2025-11-07 |
セレクティス ソシエテ アノニム |
Ｔ細胞媒介免疫療法の有効性及び安全性の増進
|
|
WO2024121380A1
(en)
|
2022-12-08 |
2024-06-13 |
Pierre Fabre Medicament |
Vaccinal composition and adjuvant
|
|
WO2024209089A1
(en)
|
2023-04-07 |
2024-10-10 |
Commissariat A L'energie Atomique Et Aux Energies Alternatives |
Use of antibody against the endothelin receptor b for diagnostic and therapeutic applications
|
|
AU2024270764A1
(en)
|
2023-05-15 |
2025-12-04 |
Nchroma Bio, Inc. |
Compositions and methods for epigenetic regulation of hbv gene expression
|
|
WO2024236547A1
(en)
|
2023-05-18 |
2024-11-21 |
Inceptor Bio, Llc |
Modified phagocytic cells expressing chimeric antigen receptors comprising a herpes virus entry mediator (hvem) co-stimulatory domain and uses thereof
|
|
WO2024246301A1
(en)
|
2023-06-02 |
2024-12-05 |
Cellectis Sa |
Methods for identifying tale base editors off-sites
|
|
WO2025046513A1
(en)
|
2023-08-29 |
2025-03-06 |
Inceptor Bio, Llc |
Methods of manufacturing myeloid-derived cells from hematopoietic stem cells and compositions and uses thereof
|
|
WO2025054540A1
(en)
|
2023-09-08 |
2025-03-13 |
Iovance Biotherapeutics, Inc. |
Methods of gene-editing using programmable nucleases
|
|
WO2025059215A1
(en)
|
2023-09-12 |
2025-03-20 |
Aadigen, Llc |
Methods and compositions for treating or preventing cancer
|
|
WO2025081123A1
(en)
|
2023-10-12 |
2025-04-17 |
Fred Hutchinson Cancer Center |
Methods and compositions for improving t cell immunotherapy
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
WO2025245169A1
(en)
|
2024-05-21 |
2025-11-27 |
Fred Hutchinson Cancer Center |
Immunotherapy cells equipped with a collagen-targeting payload
|
|
WO2025262307A2
(en)
|
2024-06-21 |
2025-12-26 |
Institut Pasteur |
Vhh suitable to vectorize molecules intracellularly
|
|
WO2025262278A1
(en)
|
2024-06-21 |
2025-12-26 |
Institut Pasteur |
A neurovita short interfering peptide suitable for neuroprotection and neuroregeneration and uses thereof
|
|
WO2026047626A1
(en)
|
2024-08-30 |
2026-03-05 |
Inceptor Bio, Llc |
Compositions and methods involving immune cells engineered for binding bispecific antibodies for use in cell therapy
|